Administration of HBOT for 2 hr a day in 6 wk on endometriosis-induced rats has demonstrated a significant lowering effect of the TNF-α level, leading to a remission of the endometriosis lesion due to the inhibition of NFκB (19). Here, TNF is linked to endometriosis.